Caribou Biosciences
CRBU
113 hedge funds and large institutions have $457M invested in Caribou Biosciences in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 21 closing their positions.
298% more call options, than puts
Call options by funds: $2.17M | Put options by funds: $545K
125% more capital invested
Capital invested by funds: $203M → $457M (+$254M)
108% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 24
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
9.58% more ownership
Funds ownership: 61.5% → 71.08% (+9.6%)
6% less funds holding
Funds holding: 120 → 113 (-7)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Elmwood Wealth Management
Berkeley,
California
|
+$22M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.9M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$5.61M |
| 4 |
Morgan Stanley
New York
|
+$5.32M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$12.2M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.89M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.96M |
| 4 |
GAA
Green Alpha Advisors
Niwot,
Colorado
|
-$1.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.57M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$135K | -24,200 | Closed |
|
127
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$107K | -18,793 | Closed |
|
|
GCP
128
GSA Capital Partners
London,
United Kingdom
| – | -$81K | -14,917 | Closed |
|
|
AI
129
Atom Investors
Austin,
Texas
| – | -$81K | -14,844 | Closed |
|
130
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$78K | -14,326 | Closed |
|
|
CG
131
Cutler Group
San Francisco,
California
| – | -$27K | -5,053 | Closed |
|
|
DFCM
132
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$7K | -1,274 | Closed |
|
|
RG
133
Retirement Group
San Diego,
California
| – | -$1K | -100 | Closed |
|
|
IUHSA
134
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| – | -$1K | -99 | Closed |
|
CRBU Hedge Fund Activity: Q3 2022 in Review
113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2022, worth a combined $457M — up 125% from $203M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of CRBU and 14 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 50 added.
The largest buyer was Elmwood Wealth Management, opening a new position worth an estimated $22M. The largest seller was Farallon Capital Management, cutting an estimated $12.2M.
- 113 institutional investors held Caribou Biosciences (CRBU) as of Q3 2022, down from 120 in Q2 2022.
- Funds reported $457M of Caribou Biosciences stock for Q3 2022, up 125% quarter-over-quarter.
- 14 funds opened new Caribou Biosciences positions in Q3 2022 and 21 closed out, a net change of -7 holders.
- The largest Caribou Biosciences buyer in Q3 2022 was Elmwood Wealth Management, an estimated $22M added.
- The largest Caribou Biosciences seller in Q3 2022 was Farallon Capital Management, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2022.